34 SHARE-BASED PAYMENTS (CONTINUED)
(ii) Restricted Issue
The key features of the restricted issue as stated in circular to shareholders dated 4 November 2014 are as follows:
(a) The restricted issue is intended to enable the resident consultant under the KPJ Group, who are not eligible to
participate in the ESOS, to also have an opportunity to share and invest in the equity growth of the Company as
well as to serve as a reward to the resident consultants for their overall contribution to the KPJ Group.
(b) The resident consultant is offered to purchase allocated shares at the discounted price (below market price) and
to be accepted within the allocated period.
The fair value of the discount amounting to RM7,004,000 relating to 17,509,000 shares at RM0.40 per share has been
recognised as an expense during the financial year.
35 OTHER RESERVES
Warrant
reserve
(Note a)
RM'000
Merger
reserve
(Note b)
RM’000
Exchange
reserve
(Note c)
RM’000
Revaluation
reserves
(Note d)
RM’000
Share option
reserve
(Note e)
RM’000
Total
RM’000
Group
At 1 January 2015
31,952
(3,367)
1,895
58,429
–
88,909
Other comprehensive income
Translation of foreign subsidiaries
–
–
(3,923)
–
–
(3,923)
Revaluation surplus
–
–
–
47,485
–
47,485
Total other comprehensive
(loss)/income
–
–
(3,923)
47,485
–
43,562
Total comprehensive (loss)/income
–
–
(3,923)
47,485
–
43,562
Transactions with owners:
Issue of shares:
– warrants
(259)
–
–
–
–
(259)
– ESOS
–
–
–
–
(674)
(674)
(259)
–
–
–
(674)
(933)
ESOS granted during the year
–
–
–
–
26,477
26,477
Lapsed ESOS
–
–
–
–
(1,307)
(1,307)
At 31 December 2015
31,693
(3,367)
(2,028)
105,914
24,496 156,708
317
KPJ Healthcare Berhad
Annual Report
2015
NOTES TO THE
FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2015 (CONTINUED)
